In the context of tumors, PD-1 expression is maintained at high levels, leading to a state of T cell exhaustion, with progressive loss of function and proliferative capacity [38], contributing to immunosuppressive tumor microenvironment (TME), and to promote epithelial–mesenchymal transition [47]. Here, PDCD1 is linked to neoplasm.